Drugmaker Eli Lilly Reportedly Settles Class-Action Insulin Lawsuit
Indianapolis-based drugmaker Eli Lilly reportedly agreed May 26 to pay $13.5 million to settle a class-action lawsuit alleging the company has for years overpriced insulin products.
Read More